You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian cancer

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian cancer

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202314440107
Dec 202315808
Jan 20249108
Feb 202413409
Mar 2024160012
Apr 202498014
May 202474010
Jun 2024134010
Jul 202412803
Aug 2024128011
Sep 2024102011
Oct 20248609
Nov 2024172016
Dec 202410308
Jan 202597018
Feb 20252607
Mar 2025008
Apr 2025009
May 20250011
Jun 2025007
Total31350296